Open-label Study of Initial and Repeat Treatment Cycles of Hylan G-F 20 in Patients with Symptomatic Knee Osteoarthritis

about

Open-label Study of Initial and Repeat Treatment Cycles of Hylan G-F 20 in Patients with Symptomatic Knee Osteoarthritis

Item

http://www.wikidata.org/entity/Q37402778

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Open-label Study of Initial an ...... ymptomatic Knee Osteoarthritis

@en

Open-label Study of Initial an ...... mptomatic Knee Osteoarthritis.

@nl

type

Item

label

Open-label Study of Initial an ...... ymptomatic Knee Osteoarthritis

@en

Open-label Study of Initial an ...... mptomatic Knee Osteoarthritis.

@nl

prefLabel

Open-label Study of Initial an ...... ymptomatic Knee Osteoarthritis

@en

Open-label Study of Initial an ...... mptomatic Knee Osteoarthritis.

@nl

P1476

Open-label Study of Initial an ...... ymptomatic Knee Osteoarthritis

@en

P2093

Günther Paulsen

http://www.w3.org/2001/XMLSchema#string

Michael Kresmann

http://www.w3.org/2001/XMLSchema#string

Robert Heger

http://www.w3.org/2001/XMLSchema#string

Ulrich Fickert

http://www.w3.org/2001/XMLSchema#string

P2860

Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action

Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in Canada.

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

Long-Term (1-Year) Safety and Efficacy of a Single 6-mL Injection of Hylan G-F 20 in Indian Patients with Symptomatic Knee Osteoarthritis

Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?

EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis.

Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials.

Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee.

Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review.

P304

88-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2174/1874312901610010088

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27867433

http://www.w3.org/2001/XMLSchema#string

P921

osteoarthritis

P932

5101633

http://www.w3.org/2001/XMLSchema#string